The state of Maryland is the global epicenter of vaccine research and development. This has never been more evident than right now as scores of Maryland companies have risen to the global challenge of developing the first approved vaccine for SARS-CoV-2.
Maryland Startup Apsis Healthcare Systems Striving to Simplify Drug Development Where Technology and Biology Meet
University of Maryland alumni, Sathya Janardhanan, founded Apsis Healthcare Systems in 2018 to help biotech and pharma companies of all sizes simplify drug development through process automation and leveraging the power of Big Data.
Whether it’s “Mom and Pop” retail storefronts, family-run home services companies or life science companies developing innovative, life saving products, family owned-and-operated businesses are the lifeblood of the global economy.
Maryland’s Longhorn Vaccines & Diagnostics Set to Launch New Product that Could Revolutionize Molecular Testing
Longhorn Vaccines & Diagnostics, which has offices in Bethesda, Maryland, and San Antonio, Texas, has been at the forefront of the battle against COVID-19. And now, the innovative company has released its latest product, PrimeStore Analyte Transport Media (ATM)Ⓡ, which could revolutionize antigen and molecular testing by completely eliminating the need for RNA and DNA extraction.
The 6th annual Biohealth Capital Region (BHCR) Forum kicks off on October 19th. This year’s event will be held virtually and will bring together the top biotech and life science executives and expert speakers from across the industry, academia, healthcare, government, finance, and real estate development, among others.
On September 9, 2020, Bloomberg reported that Apple will distribute The ClearMask, along with its own masks, as PPE to its store and corporate employees.
Maryland is the epicenter of biotech and life science innovation in the BioHealth Capital Region (BHCR). The state is home to a burgeoning life science ecosystem, including a rapidly growing cell and gene therapy industry, a robust and growing advanced biomanufacturing environment, and a deep network of leading research universities and critical government life science research entities.
Veteran Biotech Founder Marco Chacon Joins Industry Leaders to Teach High School Students about Careers in Biotech in Virtual Lecture Series
Marco Chacon, the former Paragon Bioservices, now Catalent Gene Therapy, founder was among the top industry leaders who participated in a unique biotech workforce lecture series this past Summer.
Aurinia Pharmaceuticals Prepares for Commercial Launch from New Maryland Site on the Heels of 2020 Hiring Spree
Aurinia Pharmaceuticals (Aurinia) is a late-stage clinical biopharmaceutical company (Toronto Stock Exchange (TSX:AUP); NASDAQ (NASDAQ:AUPH) focused on commercializing therapies for rare autoimmune and inflammatory conditions.
Graybug Vision files for $86 Million IPO on NASDAQ (GRAY)